Detalles de la búsqueda
1.
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Cancer Res Commun
; 2(11): 1504-1519, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36970050
2.
EVT-701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti-tumor activity in models of solid cancers.
Pharmacol Res Perspect
; 9(5): e00854, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478236
3.
Facilitation of addition-elimination reactions in pyrimidines and purines using trifluoroacetic acid in trifluoroethanol.
Chem Commun (Camb)
; (22): 2802-3, 2003 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-14651112
4.
N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist.
J Med Chem
; 57(17): 7293-316, 2014 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25075638
5.
5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.
J Med Chem
; 56(23): 9441-56, 2013 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24175584
Resultados
1 -
5
de 5
1
Próxima >
>>